FB Pixel no scriptNews | KrASIA
MENU
KrASIA

News

News

Innogen bets on longer-lasting GLP-1 drugs to stand out in crowded field

The company hopes to stand out with Diabegone, a diabetes treatment that lasts longer than competing drugs from companies like Novo Nordisk and Eli Lilly.

4 mins read
  • China’s semiconductor scene is shifting fast under the pressure of AI demand and supply constraints.

    News

    China Recap | Chipmakers in motion

    2 mins read

Most Recent

See All